Amlan Das

3.7k total citations · 1 hit paper
90 papers, 2.8k citations indexed

About

Amlan Das is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Amlan Das has authored 90 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Physiology. Recurrent topics in Amlan Das's work include Bacterial biofilms and quorum sensing (6 papers), Cancer-related Molecular Pathways (6 papers) and Connective Tissue Growth Factor Research (6 papers). Amlan Das is often cited by papers focused on Bacterial biofilms and quorum sensing (6 papers), Cancer-related Molecular Pathways (6 papers) and Connective Tissue Growth Factor Research (6 papers). Amlan Das collaborates with scholars based in India, United States and France. Amlan Das's co-authors include Gopal Chakrabarti, Wei Guo, Diptiman Choudhury, Shanshan Feng, Xiaoyu Zhang, Jian Zhang, Andreas Knödler, Johan Peränen, Peter Haddad and Arnab Ganguli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Amlan Das

86 papers receiving 2.8k citations

Hit Papers

The emerging role of microplastics in systemic toxicity: ... 2023 2026 2024 2025 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amlan Das India 31 1.2k 479 340 338 213 90 2.8k
Yanhong Wang China 31 1.6k 1.3× 175 0.4× 321 0.9× 153 0.5× 224 1.1× 125 3.2k
Fernando Rodrigues‐Lima France 32 1.6k 1.3× 311 0.6× 126 0.4× 158 0.5× 179 0.8× 120 2.7k
Mauro Angeletti Italy 36 1.7k 1.3× 302 0.6× 268 0.8× 173 0.5× 583 2.7× 140 3.6k
Keiko Yamamoto Japan 36 1.5k 1.2× 452 0.9× 641 1.9× 755 2.2× 243 1.1× 173 4.2k
Hui Liu China 34 1.7k 1.4× 158 0.3× 463 1.4× 154 0.5× 420 2.0× 234 4.1k
Lele Zhang China 33 1.5k 1.2× 129 0.3× 212 0.6× 151 0.4× 95 0.4× 175 3.5k
C. Channa Reddy United States 40 1.8k 1.5× 164 0.3× 394 1.2× 170 0.5× 293 1.4× 114 4.3k
Umesh C. S. Yadav India 32 1.4k 1.1× 497 1.0× 239 0.7× 146 0.4× 473 2.2× 95 3.9k
Camillo Rosano Italy 42 2.0k 1.6× 310 0.6× 1.3k 3.7× 613 1.8× 441 2.1× 143 4.4k
Kyôko Takahashi Japan 40 1.9k 1.5× 794 1.7× 787 2.3× 172 0.5× 640 3.0× 209 5.0k

Countries citing papers authored by Amlan Das

Since Specialization
Citations

This map shows the geographic impact of Amlan Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amlan Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amlan Das more than expected).

Fields of papers citing papers by Amlan Das

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amlan Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amlan Das. The network helps show where Amlan Das may publish in the future.

Co-authorship network of co-authors of Amlan Das

This figure shows the co-authorship network connecting the top 25 collaborators of Amlan Das. A scholar is included among the top collaborators of Amlan Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amlan Das. Amlan Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhattacharjee, Rana, et al.. (2025). Decoding breast cancer: insights into molecular pathways & therapeutic approaches. Discover Oncology. 16(1). 2103–2103.
2.
3.
Ghosh, Moupiya, Samir Mandal, Anindya Roy, et al.. (2024). Development of an antifungal drug loaded spinel ferrite nanocarrier with enhanced antifungal activity and superior anticancer effect against human lung carcinoma cells. Journal of Molecular Structure. 1307. 137925–137925. 5 indexed citations
7.
Paul, Payel, et al.. (2021). Piperine exhibits promising antibiofilm activity against Staphylococcus aureus by accumulating reactive oxygen species (ROS). Archives of Microbiology. 204(1). 59–59. 19 indexed citations
8.
Chakraborty, Poulomi, Payel Paul, Monika Kumari, et al.. (2021). Attenuation of Pseudomonas aeruginosa biofilm by thymoquinone: an individual and combinatorial study with tetrazine-capped silver nanoparticles and tryptophan. Folia Microbiologica. 66(2). 255–271. 21 indexed citations
9.
Paul, Payel, Poulomi Chakraborty, Sarita Sarkar, et al.. (2021). 1,4-Naphthoquinone disintegrates the pre-existing biofilm of Staphylococcus aureus by accumulating reactive oxygen species. Archives of Microbiology. 203(8). 4981–4992. 11 indexed citations
10.
Paul, Payel, Poulomi Chakraborty, Ahana Chatterjee, et al.. (2021). Tryptophan interferes with the quorum sensing and cell surface hydrophobicity of Staphylococcus aureus: a promising approach to inhibit the biofilm development. 3 Biotech. 11(8). 376–376. 13 indexed citations
11.
Mehta, Meenu, Keshav Raj Paudel, Shakti D. Shukla, et al.. (2021). Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. Journal of Controlled Release. 337. 629–644. 28 indexed citations
12.
Paul, Payel, Poulomi Chakraborty, Ahana Chatterjee, et al.. (2020). 1,4-Naphthoquinone accumulates reactive oxygen species in Staphylococcus aureus: a promising approach towards effective management of biofilm threat. Archives of Microbiology. 203(3). 1183–1193. 33 indexed citations
13.
Maity, Gargi, Arnab Ghosh, Inamul Haque, et al.. (2019). CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 18(4). 788–800. 30 indexed citations
14.
Das, Amlan, et al.. (2019). Gold nanoparticle-assisted enhancement in the anti-cancer properties of theaflavin against human ovarian cancer cells. Materials Science and Engineering C. 104. 109909–109909. 33 indexed citations
16.
Das, Amlan, et al.. (2014). One-Step Green Synthesis and Characterization of Flower Extract-Mediated Mercuric Oxide (HgO) Nanoparticles from Callistemon Viminalis.. 2(2). 25–28. 2 indexed citations
17.
Kambhampati, Suman, Roger A. Rajewski, Inamul Haque, et al.. (2013). A Second-Generation 2-Methoxyestradiol Prodrug Is Effective against Barrett's Adenocarcinoma in a Mouse Xenograft Model. Molecular Cancer Therapeutics. 12(3). 255–263. 22 indexed citations
18.
Pérez‐Cruz, Fernanda, Frederick A. Villamena, Gerald Zapata‐Torres, et al.. (2013). Selected hydroxycoumarins as antioxidants in cells: physicochemical and reactive oxygen species scavenging studies. Journal of Physical Organic Chemistry. 26(10). 773–783. 15 indexed citations
19.
Haddad, Peter, Amlan Das, Muhammad Ashfaq, & Angelika Wieck. (2009). A review of valproate in psychiatric practice. Expert Opinion on Drug Metabolism & Toxicology. 5(5). 539–551. 98 indexed citations
20.
Das, Amlan, et al.. (2008). Unexpected Complexity in the Mechanisms That Target Assembly of the Spectrin Cytoskeleton. Journal of Biological Chemistry. 283(18). 12643–12653. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026